NCT05820477Active, not recruiting
FAMS-T1D Self-Regulation and Social Support for T1D
Improving Self-Regulation and Social Support for Type 1 Diabetes During Emerging Adulthood (FAMS-T1D)
Source: ClinicalTrials.gov · Last updated 13 Nov 2025
Brief summary (registry, in English)
The goal of this clinical trial is to evaluate how effective the FAMS-T1D intervention is for improving self-regulation (e.g., setting and meeting goals for type 1 diabetes) and social support for meeting those goals for young adults. The main questions that are examined include 1) whether the intervention improves blood glucose, self-management and diabetes distress across time, 2) whether these improvements occur through better self-regulation and social-regulation, 3) whether the intervention improves outcomes for support persons (a friend or family member invited to participate by the person with diabetes) without increasing support burden and 4) whether the intervention improves for persons with diabetes who are on continuous blood glucose monitor their time in range.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 280 (estimated)
- First submitted
- 7 Apr 2023
- Start date
- 25 Apr 2023
- Primary completion date
- 31 Jan 2027
- Lead sponsor
- University of Utah
- Diseases
- Type 1 diabetes
- NCT number
- NCT05820477
What you commit to
- Study type: Interventional
- Planned participants: 280
- From 25 Apr 2023 to the primary completion date, 31 Jan 2027
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- PERSONS WITH DIABETES:
- Has a condition that would prohibit study completion (intellectual disability, blindness or auditory limitations, severe mental illness)
Other
- Plans to live outside of the country during study period.
- SUPPORT PERSON
- Shares a phone with the patient participant.
- Plans to live outside of the country during study period.
Who the study is looking for
- PERSONS WITH DIABETES
- Ages 18-24
- Have a diagnosis of T1D and has been taking insulin for at least one year
- Comfortable sending texts
- Can speak, read, and write in English
- Meets one of the following two criteria: 1) has a most recent A1c value in of 7.5% or higher (prioritizing EHR, next self-report) or missing in EHR) OR 2) screen positive for diabetes distress on the two-item Diabetes Distress Screen (DDS-2).
- SUPPORT PERSON
- Can speak, read, and write in either English or Spanish
- Comfortable sending and receiving texts
- Ages 18 and older
Age in the registry: 18 years to 24 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Children's Hospital of Los Angeles Coordinator of this site? Confirm its status | Los Angeles | United States | Unknown status |
| University of Utah Coordinator of this site? Confirm its status | Salt Lake City | United States | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.